focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.00
Ask: 4.00
Change: 0.29 (8.26%)
Spread: 1.00 (33.333%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

Thu, 30th Nov 2023 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Ashtead Technology Holdings PLC, up 20% at 582.00 pence, 12-month range 281.00p-594.00p. The subsea equipment rental, serving the offshore energy sector, says it now expects 2023 results to be "comfortably ahead of its previous expectations". It also announces a GBP53.5 million deal to acquire ACE Winches, from that firm's founders Alfie and Valerie Cheyne. ACE offers lifting, pulling and deployment services, and will sit nicely with "Ashtead Technology's existing equipment and services portfolio", it says.

----------

AIM - LOSERS

----------

Proteome Sciences PLC, down 25% at 4.54p, 12-month range 3.15p-8.79p. The protein-focused drug development services provider cuts its revenue outlook for 2023 amid delays to projects. It expects its top line to shrink from 2022's GBP7.8 million. "As reported by many other life science technology providers, the company has experienced delays to projects, many of which have been postponed to 2024. The healthcare industry has faced a very challenging market environment this year, especially in the second half of the year," Proteome Sciences explains. Proteome adds that reduced revenue combined with its commitment to invest in a US lab, means its now expects to post a net loss for 2023. In 2022, the company posted a profit after tax of GBP1.3 million. Proteome says it expects its US laboratory to be operational in the coming weeks and is lining up first customer projects for this laboratory.

----------

Totally PLC, down 16% at 4.85p, 12-month range 4.80p-38.00p. A poor week for the stock continues and it looks likely to suffer a fourth-successive share price decline. On Tuesday, the healthcare services provider in UK and Ireland reported that it swung to a pretax loss of GBP1.9 million in the first half ended September 30, from a profit of GBP1.0 million the year prior. Revenue fell 21% to GBP55.8 million during the period, from GBP70.3 million a year ago, Totally said. The firm blamed a "crisis" faced by the UK NHS for the lower revenue, given the loss of its North West London contracts. Shares have fallen 48% so far this week and it hit this 12-month low on Thursday.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Apr 2018 12:11

Proteome Sciences 2017 Loss Narrows On Revenue Growth And Cost Cuts

LONDON (Alliance News) - Life sciences firm Proteome Sciences PLC said Tuesday its annual loss narrowed in 2017 on higher revenue and lower costs, as it looks to focus growth on its biomarker loss

Read more
9 Feb 2017 11:14

Proteome Sciences trades in line as it consolidates lab facilities

(ShareCast News) - Proteome Sciences provided a trading update for the 12 months to 31 December on Thursday, saying that after a strong first half, progress continued throughout the rest of the year with results in line with expectations. The AIM-traded firm said buoyed by robust sales of its TMT re

Read more
9 Feb 2017 09:13

Proteome Sciences Expects Narrowed Loss, Appoints Commercial Officer

Read more
4 Jan 2017 16:48

DIRECTOR DEALINGS: Vehicle Of Proteome Non-Executive Buys Shares

Read more
31 Oct 2016 09:18

Proteome Sciences plunges after highly discounted placing

(ShareCast News) - After offering the shares at a highly discounted price before getting shareholder approval, Proteome Sciences has raised £3.3m through a placing and subscription of new shares to accelerate its strategy and meet client demand. The AIM-listed company issued the shares at 5p, a 45%

Read more
15 Sep 2016 10:34

Proteome Sciences shares slide as losses widen

(ShareCast News) - Proteome Sciences released its unaudited interim results for the six months to 30 June on Thursday, with revenues to 30 June increasing 32% to £1.12m. The AIM-traded company said revenue from licences, sales and services increased 44% to £1.08m during the period, while TMT reagent

Read more
16 Jun 2016 15:12

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 May 2016 08:24

Proteome Sciences Appoints New CEO As Annual Loss Narrows

Read more
5 Apr 2016 08:40

Proteome Sciences Welcomes Supportive Reports On Protein Profiling

Read more
29 Feb 2016 10:01

Proteome Sciences Starts 2016 Well, Production Capacity Up

Read more
5 Nov 2015 10:39

Proteome Sciences Gets Positive Results From CK1d Inhibitors Study

Read more
30 Sep 2015 09:15

Proteome On Track For Strong Second Half Revenue As Loss Narrows

Read more
17 Jul 2015 11:17

Proteome Sciences Expects Strong Revenue Growth On Good Pipeline

Read more
23 Jun 2015 13:26

Proteome raises £2.5m from placing

Protein biomarker company Proteome Science has placed 13.86m shares at 18p each, raising £2.5m before expenses. The proceeds will be used to increase capacity and shorten lead times ensuring the company can continue to meet the significant increase in demand for its biomarker services from a growing

Read more
23 Jun 2015 06:59

Proteome Sciences Raises GBP2.5 Million In Share Placing (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.